Deepika Chenna and Colleagues Present Systematic Review Data: Gaps in Prevention Drive Maternal Alloimmunization in India
Deepika Chenna, Additional Professor, Department of Immunohematology and Blood Transfusion at Kasturba Medical College, shared on LinkedIn:
“This systematic review showed that the overall prevalence of maternal red cell alloimmunization in India was 2 per 100. Anti-D was the most commonly identified antibody (56.4%). Despite the availability of anti-D prophylaxis, over half of the alloimmunised women had anti-D antibodies, indicating potential gaps in prevention strategies. Further research is needed to address this gap and minimize this preventable cause of fetal and neonatal complications”
Title: Prevalence of Alloimmunization and Associated Risk Factors among Antenatal Women in India: A Systematic Review and Meta-Analysis
Authors: Shamee Shastry, Deepika Chenna, Soumya Das, Vinu Rajendran, Mohandoss Murugesan, Rajendra Chaudhary
Read full article here.
Stay informed with Hemostasis Today.
-
Dec 11, 2025, 06:23Robert Negrin is the President of ASH for 2026
-
Dec 11, 2025, 03:36Susan Galbraith on AstraZeneca’s Grand Presence at ASH25
-
Dec 10, 2025, 23:50Abdul Mannan: Two Battles, One Patient – Why Women on Anticoagulants Need Better Coordinated Care
-
Dec 10, 2025, 22:0212 Posts Not to Miss From the ASH 2025 – Wolfgang Miesbach
-
Dec 10, 2025, 17:22In the Fight for Hematology: Adetokunbo O’s Reflections from ASH25
-
Dec 10, 2025, 17:11Driving Innovation in Rare Blood Disorders: Jeff Schaffnit’s ASH 2025 Perspective
-
Dec 10, 2025, 16:37Arthur Allen – The New President-Elect of the Anticoagulation Forum Board of Directors
-
Dec 10, 2025, 16:29Matthew D Neal: An Oasis in the Platelet Desert?
-
Dec 10, 2025, 16:14Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH